BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240917
DTEND;VALUE=DATE:20240921
DTSTAMP:20260515T163224
CREATED:20240513T102940Z
LAST-MODIFIED:20240513T102940Z
UID:39084-1726531200-1726876799@www.pharmajournalist.com
SUMMARY:9th CAR-TCR Summit
DESCRIPTION:The commercial success of cell therapies is continuing to grow! With a recent TIL approval\, a shift to earlier line CAR-T treatment\, and further approvals set for this year\, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity. \nThat’s why now’s the time to join the 9th CAR-TCR Summit: the industry’s definitive forum committed to progressing end-to-end cell therapy development. This year’s 2-day conference will accommodate in-depth tracks covering Discovery\, Translation\, Clinical Development\, Early-Stage Manufacturing\, Late-Stage Manufacturing\, Analytical Development and Supply Chain & Clinical Operations. \nThis is your team’s one-stop shop for all functions to discover cutting-edge innovations\, significant clinical data and gain insights into how to conquer the bottlenecks withholding optimal durability\, accessibility\, safety and cost-efficiency. \nJoin 130+ expert speakers and 1\,000+ cell therapy experts to collaborate to achieve the shared goal of delivering these curative treatments to the ever-growing population of patients in need. \nTo see the speaker faculty\, what’s new for 2024\, full session details\, who you will meet and much more\, view the full agenda now: https://ter.li/wjnrky
URL:http://www.pharmajournalist.com/event/9th-car-tcr-summit/
LOCATION:Hynes Convention Center\, 900 Boylston St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240917
DTEND;VALUE=DATE:20240920
DTSTAMP:20260515T163224
CREATED:20240515T095715Z
LAST-MODIFIED:20240515T095715Z
UID:39116-1726531200-1726790399@www.pharmajournalist.com
SUMMARY:2nd CRISPR-Based Therapy Analytical Development Summit
DESCRIPTION:Develop\, characterize\, and validate robust analytical tools that demonstrate safety\, efficacy\, and regulatory compliance of genome editing therapies \nAs CRISPR-based therapies become ever-complex\, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny\, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy\, before finalizing guidance on genome editing therapies in January. \nTo keep up with these growing analytical demands\, the 2nd CRISPR-Based Therapy Analytical Development Summit is returning to unite 50+ key figures across Analytical Development\, CMC & QC domains\, all with the common goal of developing more precise\, accurate\, and sensitive analytical assays. \nExpert discussions will highlight analytical innovation with both traditional and disruptive CRISPR-based therapies\, and span in vivo and ex vivo delivery\, covering the following core themes: \n\nCharacterization of guides\, nucleases\, and full drug constructs\nRobust non-clinical and CMC assay development\, including biodistribution studies\, potency assays\, and on-/off- target sequencing detection\, nomination\, and prediction\nMeeting regulatory expectations for analytical data to support IND submissions successfully\n\nIf you are working to develop\, characterize\, and validate more robust analytical tools to enable the progression of your early R&D work into a clinical therapy\, this is your collaborative forum to equip you with the latest innovation\, case studies\, and actionable insights to level up your analytical efforts.
URL:http://www.pharmajournalist.com/event/2nd-crispr-based-therapy-analytical-development-summit/
LOCATION:Hilton Boston Logan Airport\, One Hotel Dr\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240917
DTEND;VALUE=DATE:20240920
DTSTAMP:20260515T163224
CREATED:20240530T075911Z
LAST-MODIFIED:20240530T075911Z
UID:39192-1726531200-1726790399@www.pharmajournalist.com
SUMMARY:3rd mRNA Process Development & Manufacturing Summit
DESCRIPTION:Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification\, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond \nThe mRNA manufacturing industry is experiencing a wave of innovation with the development of cancer vaccines\, emerging therapeutics\, and novel gene editing tools. Yet\, significant challenges remain – largely around the speed\, cost of production\, and limited flexibility to improve current processes with new technologies. \nReturning to Boston this September\, the 3rd mRNA Process Development & Manufacturing Summit has been carefully put together to address the industry’s most prominent pain points. Hear from 30+ expert speakers from the likes of BioNTech\, Merck & Co.\, Moderna\, Nutcracker Therapeutics\, Pfizer\, Sanofi\, Strand Therapeutics and more across three days of content spanning two tracks dedicated to Research Scale and IND-Enabling & Clinical Scale process development. \nBoost your mRNA drug substance to drug product by implementing high throughput process development\, optimizing mRNA synthesis and purification\, speeding up process analytics and innovating formulation to unlock the unlimited potential of mRNA for all applications. \n\nDates: September 17-19\, 2024\nLocation: Westin Boston Seaport District\, Boston\, MA\nEvent Program: https://ter.li/k46oir\n\nNew for 2024\, join the mRNA Purification focus day to enhance your upstream and downstream purification processes\, or dive into 3 pre-conference workshops to harness high throughput process development technology\, master mRNA process changes\, drug quality and patient safety\, and choose the right external partner. \nDownload the agenda here: https://ter.li/k46oir \nRegister your place here (and take advantage of group discounts of up to 20% when sending your team of three or more!): https://ter.li/wf4j0
URL:http://www.pharmajournalist.com/event/3rd-mrna-process-development-manufacturing-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240917
DTEND;VALUE=DATE:20240920
DTSTAMP:20260515T163224
CREATED:20240618T121731Z
LAST-MODIFIED:20240618T121731Z
UID:39302-1726531200-1726790399@www.pharmajournalist.com
SUMMARY:2nd ADC Process Development Summit
DESCRIPTION:With cutting-edge strategies and industry insights\, the 2nd ADC Process Development Summit is back with a mission to boost conjugation yield\, optimize purification\, and streamline production to meet regulatory standards all whilst minimizing costs and timelines. \nJoin AstraZeneca\, Bristol Myers Squibb\, Pfizer and a community of industry experts in process development\, conjugation\, purification\, control\, CMC\, and engineering. With a focused discussion on process development challenges\, innovative solutions and practical takeaways\, leave equipped with the technical knowledge and connections to revolutionize your ADC manufacturing process. \nThis Summit is a must attend for everyone looking to increase conjugation yield and enhance TFF\, implement rigorous control strategies for superior drug substance quality\, develop scalable processes to cut unit operations\, accelerate production timelines\, and navigate regulatory landscapes with ease. \nDon’t miss this Summit\, where innovation meets implementation\, ensuring your ADC process development reaches its optimal efficacy and efficiency!
URL:http://www.pharmajournalist.com/event/2nd-adc-process-development-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR